Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice.
Rett syndrome (RTT) is an autism spectrum disorder (ASD) caused by mutations in the X-linked MECP2 gene that encodes methyl-CpG binding protein 2 (MeCP2). Symptoms range in severity and include psychomotor disabilities, seizures, ataxia, and intellectual disability. Symptom onset is between 6-18 mon...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4192301?pdf=render |
id |
doaj-892c6d1a265a443aa873bd1712bfba01 |
---|---|
record_format |
Article |
spelling |
doaj-892c6d1a265a443aa873bd1712bfba012020-11-24T22:03:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10952710.1371/journal.pone.0109527Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice.Min Jung ParkSusan AjaQun LiAlicia L DeganoJudith PenatiJustin ZhuoCharles R RoeGabriele V RonnettRett syndrome (RTT) is an autism spectrum disorder (ASD) caused by mutations in the X-linked MECP2 gene that encodes methyl-CpG binding protein 2 (MeCP2). Symptoms range in severity and include psychomotor disabilities, seizures, ataxia, and intellectual disability. Symptom onset is between 6-18 months of age, a critical period of brain development that is highly energy-dependent. Notably, patients with RTT have evidence of mitochondrial dysfunction, as well as abnormal levels of the adipokines leptin and adiponectin, suggesting overall metabolic imbalance. We hypothesized that one contributor to RTT symptoms is energy deficiency due to defective nutrient substrate utilization by the TCA cycle. This energy deficit would lead to a metabolic imbalance, but would be treatable by providing anaplerotic substrates to the TCA cycle to enhance energy production. We show that dietary therapy with triheptanoin significantly increased longevity and improved motor function and social interaction in male mice hemizygous for Mecp2 knockout. Anaplerotic therapy in Mecp2 knockout mice also improved indicators of impaired substrate utilization, decreased adiposity, increased glucose tolerance and insulin sensitivity, decreased serum leptin and insulin, and improved mitochondrial morphology in skeletal muscle. Untargeted metabolomics of liver and skeletal muscle revealed increases in levels of TCA cycle intermediates with triheptanoin diet, as well as normalizations of glucose and fatty acid biochemical pathways consistent with the improved metabolic phenotype in Mecp2 knockout mice on triheptanoin. These results suggest that an approach using dietary supplementation with anaplerotic substrate is effective in improving symptoms and metabolic health in RTT.http://europepmc.org/articles/PMC4192301?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Min Jung Park Susan Aja Qun Li Alicia L Degano Judith Penati Justin Zhuo Charles R Roe Gabriele V Ronnett |
spellingShingle |
Min Jung Park Susan Aja Qun Li Alicia L Degano Judith Penati Justin Zhuo Charles R Roe Gabriele V Ronnett Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. PLoS ONE |
author_facet |
Min Jung Park Susan Aja Qun Li Alicia L Degano Judith Penati Justin Zhuo Charles R Roe Gabriele V Ronnett |
author_sort |
Min Jung Park |
title |
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. |
title_short |
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. |
title_full |
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. |
title_fullStr |
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. |
title_full_unstemmed |
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. |
title_sort |
anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in mecp2-null mice. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Rett syndrome (RTT) is an autism spectrum disorder (ASD) caused by mutations in the X-linked MECP2 gene that encodes methyl-CpG binding protein 2 (MeCP2). Symptoms range in severity and include psychomotor disabilities, seizures, ataxia, and intellectual disability. Symptom onset is between 6-18 months of age, a critical period of brain development that is highly energy-dependent. Notably, patients with RTT have evidence of mitochondrial dysfunction, as well as abnormal levels of the adipokines leptin and adiponectin, suggesting overall metabolic imbalance. We hypothesized that one contributor to RTT symptoms is energy deficiency due to defective nutrient substrate utilization by the TCA cycle. This energy deficit would lead to a metabolic imbalance, but would be treatable by providing anaplerotic substrates to the TCA cycle to enhance energy production. We show that dietary therapy with triheptanoin significantly increased longevity and improved motor function and social interaction in male mice hemizygous for Mecp2 knockout. Anaplerotic therapy in Mecp2 knockout mice also improved indicators of impaired substrate utilization, decreased adiposity, increased glucose tolerance and insulin sensitivity, decreased serum leptin and insulin, and improved mitochondrial morphology in skeletal muscle. Untargeted metabolomics of liver and skeletal muscle revealed increases in levels of TCA cycle intermediates with triheptanoin diet, as well as normalizations of glucose and fatty acid biochemical pathways consistent with the improved metabolic phenotype in Mecp2 knockout mice on triheptanoin. These results suggest that an approach using dietary supplementation with anaplerotic substrate is effective in improving symptoms and metabolic health in RTT. |
url |
http://europepmc.org/articles/PMC4192301?pdf=render |
work_keys_str_mv |
AT minjungpark anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT susanaja anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT qunli anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT alicialdegano anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT judithpenati anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT justinzhuo anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT charlesrroe anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice AT gabrielevronnett anaplerotictriheptanoindietenhancesmitochondrialsubstrateusetoremodelthemetabolomeandimprovelifespanmotorfunctionandsociabilityinmecp2nullmice |
_version_ |
1725831888370663424 |